Kumiko Nagase

Suggest Changes
  • Citations Per Year
Learn More
Bortezomib blocks the activation of nuclear factor-kappaB-mediated pro-inflammatory cytokines, however, systemic inflammatory symptoms following bortezomib administration have been reported, although(More)
  • 1